Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Depomed Inc (DEPO) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 1,138,020
  • Shares Outstanding, K 61,510
  • Annual Sales, $ 342,740 K
  • Annual Income, $ -75,740 K
  • 36-Month Beta 1.38
  • Price/Sales 2.51
  • Price/Book 3.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.46 +1.89%
on 12/29/16
21.38 -16.79%
on 01/04/17
-0.15 (-0.84%)
since 12/20/16
3-Month
17.42 +2.12%
on 11/08/16
24.09 -26.15%
on 10/21/16
-6.15 (-25.69%)
since 10/20/16
52-Week
12.25 +45.22%
on 03/24/16
27.02 -34.16%
on 09/30/16
+2.34 (+15.15%)
since 01/20/16

Most Recent Stories

More News
McKesson and Morgan Stanley climb; Southwestern Energy drops

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

Research Reports Coverage on Drug Makers Stocks -- Depomed, DURECT, United Therapeutics, and Amphastar Pharma

The Drug Manufacturers industry is focused on the research, distribution, and marketing of pharmaceutical drug products. Companies in this space typically have dividend yields that are higher than the...

Depomed to Present at the Annual Piper Jaffray Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that it will participate in a fireside chat at the 28th Annual Piper Jaffray Healthcare Conference scheduled for 2:00 pm ET (11:00 am PT) on Tuesday, November...

Blog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market

Upcoming AWS Coverage on Depomed Post-Earnings Results

Upgrade Alert for Depomed (DEPO)

Depomed (NASDAQ:DEPO) was upgraded from Neutral to Buy at Mizuho today. The stock closed yesterday at $19.76 on volume of 4.7 million shares, above average daily volume of 2.2 million. DepoMed, Inc....

Downgrade Alert for Depomed (DEPO)

Depomed (NASDAQ:DEPO) was downgraded from Buy to Hold at Cantor today. The stock closed yesterday at $19.01 on volume of 10.9 million shares, above average daily volume of 2.2 million. Depomed (NASDAQ:DEPO)...

Hertz and CVS plunge; SeaWorld, Priceline gain

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

Look for Shares of Depomed to Potentially Rebound after Yesterday's 16.97% Sell Off

Depomed (NASDAQ:DEPO) traded in a range yesterday that spanned from a low of $17.42 to a high of $19.85. Yesterday, the shares fell 17.0%, which took the trading range below the 3-day low of $21.45 on...

Depomed Reports Third Quarter 2016 Financial Results

- Third Quarter Revenues of $111 million -

Drug Makers Stocks on Investors' Radar -- Amarin, Depomed, DURECT, and Biodel

Last Friday, benchmark US indices extended their bearish trend as the NASDAQ Composite ended the trading session down 0.24%; the Dow Jones Industrial Average edged 0.24% lower; and the S&P 500 closed down...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects,...

See More

Support & Resistance

2nd Resistance Point 18.45
1st Resistance Point 18.12
Last Price 17.79
1st Support Level 17.61
2nd Support Level 17.43

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.